Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant Versus Flunarizine for Vestibular Migraine Prevention
NCT07751497Phase 2Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of rimegepant in vestibular migraine (VM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
rimegepant
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on NCT07751497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751497.